U.S. Markets open in 3 hrs 59 mins

Merck & Co., Inc. (MRK.BA)

Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
104.250.00 (0.00%)
At close: 4:07PM ART
Interactive chart
Previous Close104.25
Bid104.25 x
Ask0.00 x
Day's Range104.25 - 104.25
52 Week Range97.55 - 105.00
Avg. Volume439
Market Cap2.74T
PE Ratio (TTM)66.44
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • 24/7 Wall St.3 days ago

    Top Presentations to Look for at ASCO

    The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be presented ...

  • American City Business Journals4 days ago

    ​Cambridge biotech Enumeral faces uncertain future as cash dries up

    Cambridge cancer drug developer Enumeral could be forced to downsize, file for bankruptcy or sell its assets unless it quickly raises additional capital, the company said this week. Amid the cash crunch, Enumeral said it is “exploring a range of potential transactions.” According to the company, that could include a public or private offering, debt financing, collaborations and licensing deals, or a potential merger or asset sale. A representative for Enumeral did not immediately respond to an interview request on Friday.

  • UnitedHealth's (UNH) Business Unit Collaborates with Merck
    Zacks4 days ago

    UnitedHealth's (UNH) Business Unit Collaborates with Merck

    UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).